Key facts
- This page summarizes Javad Shahidi's Form 4 filing for Centessa Pharmaceuticals plc (CNTA).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 04 Oct 2022, 16:55.
Javad Shahidi - 30 Sep 2022 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- CNTA
- Reported as of
- 30 Sep 2022
- Net transaction value
- -$24,289
- SEC form
- 4
- Accepted by SEC
- 04 Oct 2022, 16:55:26 UTC
- Prior SEC filing
- 06 Jul 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Gregory Weinhoff, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Javad Shahidi filed Form 4 for Centessa Pharmaceuticals plc (CNTA) on 04 Oct 2022.
Change
- Previous filing in this sequence was filed on 06 Jul 2022.
- Current net transaction value: -$24,289.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
This filing has been restated.
Open the amended filing.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CNTA
transaction
Ordinary Shares
Sale
- Transaction value
- $11,092
- Shares
- -2,727
- Change %
- -1.7%
- Price
- $4.07
- Shares after
- 162,273
- Date
- 30 Sep 2022
- Ownership
- Direct
- Footnotes
- F1, F2, F3
CNTA
transaction
Ordinary Shares
Sale
- Transaction value
- $13,197
- Shares
- -3,341
- Change %
- -2.1%
- Price
- $3.95
- Shares after
- 158,932
- Date
- 03 Oct 2022
- Ownership
- Direct
- Footnotes
- F1, F2, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Footnote F2
The sales reported represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted share units and do not represent discretionary trades by the Reporting Person.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.93 to $4.255, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Footnote F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.765 to $4.0499, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.